Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk
Authors:
- 23 February 2012
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 33 (4) , 1125-1132
Abstract
A great number of studies regarding the association between MspI and Ile462Val polymorphisms in the CYP1A1 gene and gastric cancer have been published. However, the results have been inconsistent. In this study, a meta-analysis was performed to investigate the associations. Published literature from PubMed, ISI Web of Science and other Chinese databases were searched for eligible publications. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random or fixed effect model. Nine studies (860 cases/2183 controls) for CYP1A1 MspI polymorphism and nine studies (1161 cases/3273 controls) for CYP1A1 Ile462Val polymorphism were included in this meta-analysis. MspI polymorphism was not associated with gastric cancer risk (dominant model, OR = 0.95, 95%CI 0.80–1.14; recessive model, OR = 1.01, 95%CI 0.76–1.35; CC vs. TT, OR = 1.03, 95%CI 0.76–1.41; TC vs. TT, OR = 0.95, 95%CI 0.78–1.15). Similarly, there was no association between Ile462Val polymorphism and gastric cancer risk (dominant model, OR = 0.93, 95%CI 0.79–1.10; recessive model, OR = 1.34, 95%CI 0.90–2.00; GG vs. AA, OR = 1.27, 95%CI 0.84–1.90; AG vs. AA, OR = 0.87, 95%CI 0.71–1.07). In the subgroup analysis, no significant association was found in ever smokers, never smokers, Asians and Caucasians. This meta-analysis suggested that there were no associations between CYP1A1 polymorphisms and gastric cancer.Keywords
This publication has 38 references indexed in Scilit:
- CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and reviewJournal of Experimental & Clinical Cancer Research, 2011
- Genomic and genetic alterations influence the progression of gastric cancerWorld Journal of Gastroenterology, 2011
- Comparative epidemiology of gastric cancer between Japan and ChinaWorld Journal of Gastroenterology, 2011
- Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of stomach cancer: a hospital-based case-control study in JapanGastric Cancer, 2009
- Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian populationBMC Cancer, 2007
- GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomasCancer Detection Prevention, 2007
- Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in TaiwanJournal of Biomedical Science, 2006
- Relationship between genetic polymorphisms of drug-metabolizing enzymes ( CYP1A1 , CYP2E1 , GSTM1 , and NAT2 ), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancerJournal of Gastroenterology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986